Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review

Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare but severe disorder that frequently has a genetic component and results from the overactivation of the alternative complement pathway. As research moves toward improved diagnosis and therapy of aHUS, it will be important to better understand its epidemiology. Our objective was to conduct a systematic literature review to assess the incidence and prevalence estimates of aHUS globally. A comprehensive literature search was conducted in Embase and MEDLINE. Additionally, practice guidelines, databases of national/international organizations, and regulatory agencies were searched. From 2960 publications identified via MEDLINE and Embase, 105 publications were eligible for full-text screening, and a total of eight full-text articles met eligibility criteria for inclusion. Regional epidemiologic estimates were obtained for Europe and Oceania. Country-specific data were available for France, Norway, Australia, and Italy. Four of the identified studies reported on the prevalence of aHUS, prevalence in the age group of 20 years or younger was ranging from 2.2 to 9.4 per million population, while the only study that reported prevalence in all ages showed a prevalence of 4.9 per million population. Six studies reported on the incidence of aHUS, annual incidence in the age group of 20 years or younger was ranging from 0.26 to 0.75 per million population, and for all ages, annual incidence was ranging from 0.23 to 1.9 per million population. To our knowledge, this is the first systematic review conducted to provide a comprehensive overview of global incidence and prevalence estimates of aHUS. In general, incidence estimates were similar across all the studies; however, prevalence data were found to be more variable. Study limitations were related to inconsistencies in the definitions of aHUS between studies and also a dearth of epidemiological studies assessing incidence and prevalence of aHUS outside of Europe.

[1]  J. Brok,et al.  Risk factors for neonatal sepsis in Sub-Saharan Africa: a systematic review with meta-analysis , 2022, BMJ Open.

[2]  C. Vigneau,et al.  Etiology and Outcomes of Thrombotic Microangiopathies. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[3]  M. Nangaku,et al.  Pathogenesis of Atypical Hemolytic Uremic Syndrome , 2019, Journal of atherosclerosis and thrombosis.

[4]  Arvind Bagga,et al.  Atypical Hemolytic‐Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment , 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[5]  R. Go,et al.  Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management. , 2018, Journal of immunological methods.

[6]  G. Ardissino,et al.  Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. , 2018, Kidney international.

[7]  B. Berger.  Atypical hemolytic uremic syndrome: a syndrome in need of clarity , 2018, Clinical kidney journal.

[8]  M. Sadeghian,et al.  The Prevalence and Incidence of Atypical Hemolytic Uremic Syndrome in Iran: A Systematic Review and Meta-Analysis Protocol Study , 2017 .

[9]  V. Frémeaux-Bacchi,et al.  Haemolytic uraemic syndrome , 2017, The Lancet.

[10]  Kuixing Zhang,et al.  Atypical Hemolytic Uremic Syndrome: A Brief Review , 2017, Hematology reports.

[11]  M. Nangaku,et al.  Atypical hemolytic uremic syndrome , 2017, Renal Replacement Therapy.

[12]  G. Ardissino,et al.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2017, Kidney international.

[13]  G. Ardissino,et al.  Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network , 2016, European Journal of Pediatrics.

[14]  J. Craig,et al.  The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study , 2016, Archives of Disease in Childhood.

[15]  C. Wanner,et al.  Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  W. Hoy,et al.  The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia , 2014, Orphanet Journal of Rare Diseases.

[17]  Lawrence Copelovitch,et al.  Current treatment of atypical hemolytic uremic syndrome. , 2014, Intractable & rare diseases research.

[18]  H. Bangstad,et al.  Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999–2008 – a retrospective study of hospital records to assess the sensitivity of surveillance , 2014, BMC Infectious Diseases.

[19]  T. Goodship,et al.  Atypical Hemolytic Uremic Syndrome , 2013, Seminars in nephrology.

[20]  Y. Fujimura.  [Atypical hemolytic uremic syndrome]. , 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[21]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[22]  J. Laurence.  Atypical hemolytic uremic syndrome (aHUS): making the diagnosis. , 2012, Clinical advances in hematology & oncology : H&O.

[23]  C. Loirat,et al.  Atypical hemolytic uremic syndrome , 2011, Orphanet journal of rare diseases.

[24]  C. Sautès-Fridman,et al.  Alternative complement pathway assessment in patients with atypical HUS. , 2011, Journal of immunological methods.

[25]  G. Remuzzi,et al.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[26]  C. Rudin,et al.  Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997–2003 , 2010, European Journal of Pediatrics.

[27]  Lawrence Copelovitch,et al.  Streptococcus pneumoniae–Associated Hemolytic Uremic Syndrome: Classification and the Emergence of Serotype 19A , 2010, Pediatrics.

[28]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[29]  H. Karch,et al.  Epidemiology, Clinical Presentation, and Pathophysiology of Atypical and Recurrent Hemolytic Uremic Syndrome , 2006, Seminars in thrombosis and hemostasis.

[30]  S. Vesely,et al.  The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency , 2005, Journal of thrombosis and haemostasis : JTH.

[31]  P. Sockett,et al.  Prospective surveillance of Canadian children with the haemolytic uraemic syndrome , 2005, Pediatric Nephrology.

[32]  G. Remuzzi,et al.  Hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[33]  D. Morse,et al.  Hemolytic Uremic Syndrome Incidence in New York , 2004, Emerging infectious diseases.

[34]  A. Al-Eisa,et al.  Hemolytic uremic syndrome in Kuwaiti Arab children , 2001, Pediatric Nephrology.

[35]  E. Elliott,et al.  Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features , 2001, Archives of disease in childhood.

[36]  A. Cnaan,et al.  ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease and Hypertension Non-Enteropathic Hemolytic Uremic Syndrome: Causes and Short-Term Course , 2004 .